Surgical Innovations Group plc provided revenue guidance for the year ended 31 December 2022. For the year, the company revenues are expected to be approximately £11.3 million, an increase of more than 20% compared with the prior year (2021: £9.1 million) and 6% ahead of the pre-pandemic reference year (2019: £10.7 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.65 GBX | -7.14% |
|
0.00% | +8.33% |
19/06 | Surgical Innovations Group plc Announces the Termination of Mr. Paul James Hardy as Director | CI |
10/06 | Surgical Innovations names Weir's Chris Martin as CFO | AN |
![Consensus](/images/consensus_flch.gif)
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.33% | 84.6L | |
-4.35% | 18TCr | |
-2.67% | 10TCr | |
-6.92% | 4.62TCr | |
+18.16% | 4.48TCr | |
+9.84% | 4.44TCr | |
+14.18% | 2.95TCr | |
+22.31% | 2.58TCr | |
-7.13% | 2.4TCr | |
+3.59% | 2.25TCr |
- Stock Market
- Equities
- SUN Stock
- News Surgical Innovations Group plc
- Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022